SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

507

Zoetis

ZTS

Looking for leads, investment insights, or competitive intelligence?

CEO

Juan Ram�n Alaix

CEO Title

Chairman & Chief Executive Officer

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

Parsippany, N.J.

Years on Fortune 500 List

-

Employees

9,200

Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$5,3078.6%
Profits ($M)$864.05.2%
Assets ($M)$8,586
Total Stockholder Equity ($M)$1,770
Market Value — as of March 29, 2018 ($M)$40,524
Profit Ratios
Profit as % of Revenues16.3%
Profits as % of Assets10.1%
Profits as % of Stockholder Equity48.8%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)1.75
EPS % Change (from 2016)6.1%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-
Total Return
Total Return to Investors (2017)35.5%
Total Return to Investors (5 year, annualized)-
Total Return to Investors (10 year, annualized)-
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Zoetis

Valeant Is Said to Be Hiring This Zoetis Exec as Its New CFO

He served as senior vice president of finance operations at Zoetis.

Read More →
Pfizer Breakup May Depend on Trump or Clinton Winning the Election

Splitting itself up could depend on the next President's tax plan.

Read More →
Bill Ackman Just Unloaded $800 Million in Shares of This Pharma Firm

The animal drug company Zoetis was spun off from Pfizer in 2013.

Read More →